Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine

Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally.

Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market.

Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market. Table of ContentsFront MatterSummary1 Introduction2 The Scope of the Problem3 The Health and Economic Burden of Resistance4 Strengthening Surveillance5 Stewardship and Infection Prevention6 Bringing New Products to Market and Ensuring Their Reach7 The National Action Plan for Combating Antibiotic-Resistant Bacteria8 A Role for the United States in Coordinated Global ActionAppendix A: Committee Member BiographiesAppendix B: Disclosure of Unavoidable Conflict of InterestAppendix C: Open Session Agendas